Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I

European Journal of Heart Failure

Volumn 15, Issue 9, 2013, Pages 986-994

  Hollingsworth, Kieren G ^a   Willis, Tracey A ^a   Bates, Matthew G D ^a,b   Dixon, Ben J ^a   Lochmüller, Hanns ^a   Bushby, Kate ^a   Bourke, John ^b   MacGowan, Guy A ^a,b   Straub, Volker ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Cardiac tagging; Limb girdle muscular dystrophy; MRI; Muscular dystrophy; Spectroscopy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHORUS 31;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCARDIUM; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART STROKE VOLUME; HUMAN; IMAGE ANALYSIS; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MUSCLE STRAIN; MYOPATHY; ONSET AGE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SUBEPICARDIAL DYSFUNCTION; SYSTOLIC HEART FAILURE; TISSUE STRUCTURE; TORSION;

CARDIAC TAGGING; LIMB GIRDLE MUSCULAR DYSTROPHY; MRI; MUSCULAR DYSTROPHY; SPECTROSCOPY;

ADULT; AGED; FEMALE; HEART; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; PERICARDIUM; PROSPECTIVE STUDIES; PROTEINS; SPECTRUM ANALYSIS; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84883173095     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hft057     Document Type: Article

References (41)

1. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, Anderson LVB, Bashir R, Burgunder JM, Fallet S, Romero N, Fardeau M, Straub V, Storey G, Pollitt C, Richard I, Sewry CA, Bushby K, Voit T, Blake DJ, Muntoni F. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001;10:2851-2859. (Pubitemid 34030916)
2. Norwood FLM, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 2009;132:3175-3186.
3. Frosk P, Greenberg CR, Tennese AAP, Lamont R, Nylen E, Hirst C, Frappier D, Roslin NM, Zaik M, Bushby K, Straub V, Zatz M, de Paula F, Morgan K, Fujiwara TM, Wrogemann K. The most common mutation in FKRP causing limb girdle muscular dystrophy type 21 (LGMD21) may have occurred only once and is present in hutterites and other populations. Hum Mut 2005;25:38-44. (Pubitemid 40075912)
4. Stensland E, Lindal S, Jonsrud C, Torbergsen T, Bindoff LA, Rasmussen M, Dahl A, Thyssen F, Nilssen O. Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with limb girdle muscular dystrophy 2I. Neuromusc Disord 2011;21:41-46.
5. Sveen ML, Schwartz M, Vissing J. High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Ann Neurol 2006; 59:808-815. (Pubitemid 43673158)
6. Wahbi K, Meune C, Hamouda EH, Stojkovic T, Laforet P, Becane HM, Eymard B, Duboc D. Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Neuromusc Disord 2008;18:650-655.
7. Gaul C, Deschauer M, Tempelmann C, Vielhaber S, Klein HU, Heinze HJ, Zierz S, Grothues F. Cardiac involvement in limb-girdle muscular dystrophy 2I-conven-tional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 2006; 253:1317-1322. (Pubitemid 44691556)
8. Bushby K, Muntoni F, Bourke JP. 107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. Neuromusc Disord 2003;13:166-172. (Pubitemid 36140013)
9. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
10. Ishikawa Y, Bach JR, Minami R. Cardioprotection for Duchenne's muscular dystrophy. Am Heart J 1999;137:895-902. (Pubitemid 29226300)
11. Michele DE, Kabaeva Z, Davis SL, Weiss RM, Campbell KP. Dystroglycan matrix receptor function in cardiac myocytes is important for limiting activity-induced myocardial damage. Circ Res 2009;105:984-993
12. MacGowan GA, Shapiro EP, Azhari H, Siu CO, Hees PS, Hutchins GM, Weiss JL, Rademakers FE. Noninvasive measurement of shortening in the fiber and crossfiber directions in the normal human left ventricle and in idiopathic dilated cardio-myopathy. Circulation 1997;96:535-541. (Pubitemid 27329430)
13. Rademakers FE, Rogers WJ, Guier WH, Hutchins GM, Siu CO, Weisfeldt ML, Weiss JL, Shapiro EP. Relation of regoional cross-fiber shortening to wall thickening in the intact heart-3-dimensional strain analysis by NMR tagging. Circulation 1994;89:1174-1182. (Pubitemid 24076543)
14. Arts T, Reneman RS, Veenstra PC. A model of the mechanics of the left ventricle. Ann Biomed Eng 1979;7:299-318. (Pubitemid 10109942)
15. Carmignac V, Durbeej M. Cell-matrix interactions in muscle disease. J Pathol 2012;226:200-218.
16. Grewal PK, Hewitt JE. Glycosylation defects: a new mechanism for muscular dystrophy? Hum Mol Genet 2003;12:R259-R264. (Pubitemid 37259340)
17. Muntoni F, Brockington M, Godfrey C, Ackroyd M, Robb S, Manzur A, Kinali M, Mercuri E, Kaluarachchi M, Feng L, Jimenez-Mallebrera C, Clement E, Torelli S, Sewry CA, Brown SC. Muscular dystrophies due to defective glycosylation of dys-troglycan. Acta Myol 2007;26:129-135. (Pubitemid 351668920)
18. Jones DEJ, Hollingsworth K, Fattakhova G, MacGowan G, Taylor R, Blamire A, Newton JL. Impaired cardiovascular function in primary biliary cirrhosis. Am J Physiol Gastrointest Liver Physiol 2010;298:G764-G773.
19. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003; 17:323-329. (Pubitemid 36259246)
20. Cheng S, Fernandes VRS, Bluemke DA, McClelland RL, Kronmal RA, Lima JAC. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2009;2: 191-198.
21. Fischer SE, McKinnon GC, Maier SE, Boesiger P. Improved myocardial tagging contrast. Magn Reson Med 1993;30:191-200. (Pubitemid 23223580)
22. Lumens J, Delhaas T, Arts T, Cowan BR, Young AA. Impaired subendocardial contractile myofiber function in asymptomatic aged humans, as detected using MRI. Am J Physiol Heart Circ Physiol 2006;291:H1573-157H9.
23. Van der Toorn A, Barenbrug P, Snoep G, Van der Veen FH, Delhaas T, Prinzen FW, Maessen J, Arts T. Transmural gradients of cardiac myofiber shortening in aortic valve stenosis patients using MRI tagging. Am J Physiol Heart Circ Physiol 2002;283:H1609-H1615.
24. Hollingsworth KG, Blamire AM, Keavney BD, MacGowan GA. Left ventricular torsion, energetics and diastolic function in normal human ageing. Am J Physiol Heart Circ Physiol 2012;302:H885-H892.
25. Ashford MW, Liu W, Lin SJ, Abraszewski P, Caruthers SD, Connolly AM, Yu X, Wickline SA. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. Circulation 2005; 112:2462-2467. (Pubitemid 41504496)
26. Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson W, Gottliebson WM. Circumferential strain analysis identifies strata of cardiomyop-athy in duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 2009;53:1204-1210.
27. Hagenbuch SC, Gottliebson WM, Wansapura J, Mazur W, Fleck R, Benson DW, Hor KN. Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy. Am J Cardiol 2010;105:1451-1455.
28. Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N. 3-dimensional left-ventricular deformation in hypertrophic cardiomyopathy. Circulation 1994;90: 854-867. (Pubitemid 24242755)
29. Chung J, Abraszewski P, Yu X, Liu W, Krainik AJ, Ashford M, Caruthers SD, McGill JB, Wickline SA. Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. J Am Coll Cardiol 2006;47:384-390. (Pubitemid 43063259)
30. Rosales XQ, Moser SJ, Tran T, McCarthy B, Dunn N, Habib P, Simonetti OP, Mendell JR, Raman SV. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I. J Cardiovasc Magn Reson 2011;13: 39-44.
31. Li W, Liu W, Zhong J, Yu X. Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging. J Cardiovasc Magn Reson 2009;11:40-50.
32. Wansapura JP, Millay DP, Dunn RS, Molkentin JD, Benson DW. Magnetic resonance imaging assessment of cardiac dysfunction in delta-sarcoglycan null mice. Neuromusc Disord 2011;21:68-73.
33. Ishijima M. Histopathological study on myocardial hypertrophy associated with ischemic-heart-disease. Jpn Circ J 1990;54:616-623. (Pubitemid 20366169)
34. Bolli R, Patel BS, Hartley CJ, Thornby JI, Jeroudi MO, Roberts R. Nonuniform transmural recovery of contractile function in stunned myocardium. Am J Physiol 1989;257:H375-H385.
35. Mazhari R, Omens JH, Pavelec RS, Covell JW, McCulloch AD. Transmural distribution of three-dimensional systolic strains in stunned myocardium. Circulation 2001;104:336-341. (Pubitemid 32666957)
36. Crilley JG, Boehm EA, Rajagopalan B, Blamire AM, Styles P, Muntoni F, Hilton-Jones D, Clarke K. Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy. J Am Coll Cardio 2000;36: 1953-1958.
37. Zhang W, Ten Hove M, Schneider JE, Stuckey DJ, Sebag-Montefiore L, Bia BL, Radda GK, Davies KE, Neubauer S, Clarke K. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. J Mol Cell Cardiol 2008;45:754-760.
38. Strauer BE, Beer K, Heitlinger K, Hofling B. Left ventricular systolic wall stress as a primary determinant of myocardial oxygen consumption: comparative studies in patients with normal left ventricular function, with pressure and volume overload and with coronary heart disease. Basic Res Cardiol 1977;72:306-313. (Pubitemid 8088273)
39. Arts T, Veenstra PC, Reneman RS. Epicardial deformation and left-ventricular wall mechanics during ejection in the dog. Am J Physiol 1982;243:H379-3H90.
40. Yilmaz A, Gdynia HJ, Mahrholdt H, Sechtem U. Cardiovascular magnetic resonance reveals similar damage to the heart of patients with Becker and limb-girdle muscular dystrophy but no cardiac symptoms. J Magn Reson Imaging 2009;30:876-877.
41. Verhaert D, Richards K, Rafael-Fortney JA, Raman SV. Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging. 2011;4:67-76.